e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Hypoperfusion is the main risk factor for the development of non-tuberculous mycobacterial lung disease in CTEPH
M. Szturmowicz, K. Oniszh, E. Wilinska, A. Kacprzak, E. Augustynowicz-Kopec, M. Kurzyna, M. Wieteska, A. Torbicki, J. Kus (Warsaw, Otwock, Poland)
Source:
Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Session:
Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers
Session type:
Thematic Poster Session
Number:
2605
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Szturmowicz, K. Oniszh, E. Wilinska, A. Kacprzak, E. Augustynowicz-Kopec, M. Kurzyna, M. Wieteska, A. Torbicki, J. Kus (Warsaw, Otwock, Poland). Hypoperfusion is the main risk factor for the development of non-tuberculous mycobacterial lung disease in CTEPH. Eur Respir J 2013; 42: Suppl. 57, 2605
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Thrombophilic risk factors for chronic thromboembolic pulmonary hypertension (CTEPH) in Korea
Source: International Congress 2015 – Pulmonary circulation: pulmonary embolism and chronic thromboembolic pulmonary hypertension
Year: 2015
Chronic thromboembolic pulmonary hypertension and idiopathic pulmonary hypertension are the conditions predisposing to non-tuberculous mycobacterial lung disease (NTMLD)
Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension
Year: 2011
Risk factors of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014
The incidence of chronic thromboembolic pulmonary hypertension in asympthomatic pulmonary embolism patients
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014
HbA1c-levels in patients with operable chronic thromboembolic pulmonary hypertension
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014
Pulmonary hypertension due to lung disease
Source: International Congress 2017 – Russian Programme 2017
Year: 2017
Pulmonary embolism is more prevalent than deep vein thrombosis in cases of chronic obstructive pulmonary disease and interstitial lung diseases
Source: International Congress 2016 – Acute pulmonary embolism
Year: 2016
Risk of nontuberculous mycobacterial pulmonary disease with obstructive lung disease
Source: Eur Respir J 2016; 48: 928-931
Year: 2016
Incidence and outcomes of haemoptysis in patients with operable and non-operable chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH)
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016
Hemodynamic assessment of patients with pulmonary hypertension due to lung disease and/or hypoxia
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II
Year: 2013
Prevalence of relapses and chronic thromboembolic pulmonary hypertension (CTEPH) in patients with pulmonary embolism (PE)
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016
Pulmonary hypertension correction in patients with chronic obstructive pulmonary disease and essential hypertension
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014
Pulmonary artery dissection (PAD) in a patient with diffuse interstitial lung disease and chronic thromboembolic pulmonary hypertension (CTEPH)
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016
Clinical and prognostic scores in patients with cancer and pulmonary embolism
Source: International Congress 2016 – Acute pulmonary embolism
Year: 2016
Pulmonary embolism in COPD patients
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Mitomycin-induced pulmonary veno-occlusive disease: Experience from the French pulmonary hypertension network
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease
Source: Eur Respir J 2011; 39: 125-132
Year: 2012
Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease
Source: Eur Respir J 2012; 39: 125-132
Year: 2012
Risk factors for chronic thromboembolic pulmonary hypertension
Source: Eur Respir J 2009; 33: 325-331
Year: 2009
The incidence of chronic thromboembolic pulmonary hypertension secondary to acute pulmonary thromboembolism
Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept